beta

ABMD

ABIOMED Inc.

Abmd

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-01-2018 07-26-2018 05-03-2018 02-01-2018 10-26-2017 07-27-2017 05-04-2017 01-26-2017 10-27-2016 07-28-2016
Actual EPS 0.81 0.78 0.8 0.7 0.44 0.45 0.33 0.34 0.2 0.29
Consensus EPS 0.73 0.8 0.64 0.5 0.37 0.42 0.33 0.29 0.24 0.22
Estimated EPS 0.73 0.8 0.64 0.5 0.37 0.42 0.33 0.29 0.24 0.22
Number of Estimates 7 7 7 7 8 6 5 6 6 6
EPS Surprise $0.08 -$0.02 $0.16 $0.20 $0.07 $0.03 $0.05 -$0.04 $0.07

Stats

Summary

Abiomed Inc is a medical device company. It provides mechanical circulatory support devices to aid heart recovery to heart failure patients.

Market Cap: 10.6 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.abiomed.com

Shares Outstanding: 44.2 Million

Float: 41.4 Million

Dividend: 0.0 (0.0%)

Beta: 0.455719

Sector: Healthcare

Industry: Medical Devices

Short Interest (Jan 12, 2018): 984 Thousand

Ethical Flags

Animal testing

Longest drawdown: 218 trading days

From: 2015-08-17 To: 2016-06-28

Lowest Point:

Abiomed  A Chance To Accumulate

via: SeekingAlpha at 2018-11-19 14:36:42:000

Background If investors are not familiar with Abiomed ( ABMD ), a provider of percutaneous coronary intervention ( PCI ) devices, please see my article from the last quarter to understand what this company does, and why I believe that this could be a long term investment , that would g… read more...

Abiomed  A Chance To Accumulate

via: SeekingAlpha at 2018-11-19 14:36:42:000

Background If investors are not familiar with Abiomed ( ABMD ), a provider of percutaneous coronary intervention ( PCI ) devices, please see my article from the last quarter to understand what this company does, and why I believe that this could be a long term investment , that would g… read more...

Abiomed  A Chance To Accumulate

via: SeekingAlpha at 2018-11-19 14:36:42:000

Background If investors are not familiar with Abiomed ( ABMD ), a provider of percutaneous coronary intervention ( PCI ) devices, please see my article from the last quarter to understand what this company does, and why I believe that this could be a long term investment , that would g… read more...

Abiomed down 11% despite positive Impella CP data

via: SeekingAlpha at 2018-11-12 09:49:42:000

Abiomed ( ABMD -10.6% ) investors appear disappointed with study results that showed the benefits of unloading the left ventricle with the Impella CP heart pump for 30 minutes prior to reperfusion (restoring blood flow) in patients presenting with anterior ST-segment elevation myocardial… read more...

Abiomed down 11% despite positive Impella CP data

via: SeekingAlpha at 2018-11-12 09:49:42:000

Abiomed ( ABMD -10.6% ) investors appear disappointed with study results that showed the benefits of unloading the left ventricle with the Impella CP heart pump for 30 minutes prior to reperfusion (restoring blood flow) in patients presenting with anterior ST-segment elevation myocardial… read more...

Abiomed down 11% despite positive Impella CP data

via: SeekingAlpha at 2018-11-12 09:49:42:000

Abiomed ( ABMD -10.6% ) investors appear disappointed with study results that showed the benefits of unloading the left ventricle with the Impella CP heart pump for 30 minutes prior to reperfusion (restoring blood flow) in patients presenting with anterior ST-segment elevation myocardial… read more...

FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior to Reperfusion in Heart Attack Patients is Safe and Feasible

via: Business Wire at 2018-11-11 10:00:00:000

Abiomed will initiate pivotal randomized controlled trial with FDA Abiomed (NASDAQ: ABMD) announces the results of the FDA STEMI Door-to-Unloading safety and feasibility randomized controlled trial , which show unloading the left ventricle with Impella CP for 30 minutes p… read more...

Abiomed Continues To Be An Attractive Investment In 2018

via: SeekingAlpha at 2018-11-02 17:51:49:000

I have always been an admirer of Abiomed ( ABMD ) and have explained my hypothesis for liking this stock in this article and also this article . My admiration for the company has grown even more, after I went through its latest earnings released on November 1. Abiomed has reported revenue… read more...

Abiomed Continues To Be An Attractive Investment In 2018

via: SeekingAlpha at 2018-11-02 17:51:49:000

I have always been an admirer of Abiomed ( ABMD ) and have explained my hypothesis for liking this stock in this article and also this article . My admiration for the company has grown even more, after I went through its latest earnings released on November 1. Abiomed has reported revenue… read more...

Abiomed Continues To Be An Attractive Investment In 2018

via: SeekingAlpha at 2018-11-02 17:51:49:000

I have always been an admirer of Abiomed ( ABMD ) and have explained my hypothesis for liking this stock in this article and also this article . My admiration for the company has grown even more, after I went through its latest earnings released on November 1. Abiomed has reported revenue… read more...

Abiomed Continues To Be An Attractive Investment In 2018

via: SeekingAlpha at 2018-11-02 17:51:49:000

I have always been an admirer of Abiomed ( ABMD ) and have explained my hypothesis for liking this stock in this article and also this article . My admiration for the company has grown even more, after I went through its latest earnings released on November 1. Abiomed has reported revenue… read more...

Abiomed Continues To Be An Attractive Investment In 2018

via: SeekingAlpha at 2018-11-02 17:51:49:000

I have always been an admirer of Abiomed ( ABMD ) and have explained my hypothesis for liking this stock in this article and also this article . My admiration for the company has grown even more, after I went through its latest earnings released on November 1. Abiomed has reported revenue… read more...

JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action

via: SeekingAlpha at 2018-11-02 07:59:00:000

Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov… read more...

JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action

via: SeekingAlpha at 2018-11-02 07:59:00:000

Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov… read more...

JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action

via: SeekingAlpha at 2018-11-02 07:59:00:000

Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov… read more...

JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action

via: SeekingAlpha at 2018-11-02 07:59:00:000

Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov… read more...

JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action

via: SeekingAlpha at 2018-11-02 07:59:00:000

Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov… read more...

ABIOMED (ABMD) Q2 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-01 13:16:07:000

ABIOMED, Inc. (ABMD) Q2 2019 Earnings Call November 01, 2018 8:00 am ET Executives Ingrid Goldberg - ABIOMED, Inc. Michael R. Minogue - ABIOMED, Inc. Todd A. Trapp - ABIOMED, Inc. Analysts Chris Pasquale - Guggenheim Securities LLC Jayson T. Bedford - Raymond James & … read more...

ABIOMED, Inc. 2018 Q2 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-11-01 11:42:32:000

The following slide deck was published by ABIOMED, Inc. in conjunction with their 2018 Q2 earnings Read more … read more...

Abiomed beats by $0.08, beats on revenue

via: SeekingAlpha at 2018-11-01 07:14:51:000

Abiomed (NASDAQ: ABMD ): Q2 Non-GAAP EPS of $0.81 beats by $0.08 ; GAAP EPS of $1.09 beats by $0.36 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-10-31 17:30:40:000

AAON , AAWW , ABMD , AGIO , ALE , AMAG , AMCX , AME , AMRN , ARES , AROC , ARW , AVP , AYR , BCE , BID , BLL , BMCH , BSIG , CBRE , CCOI , CEIX , CHD , CHSP , CI , CJ , CNQ , CNSL , CWT , D , DM , DNOW , DWDP , EEX , EGRX , EPAM , EXC , EXLS , FLWS , F… read more...

Abiomed continues slide, down 8%

via: SeekingAlpha at 2018-10-25 10:11:26:000

ABIOMED ( ABMD -7.7% ) is down in early trade. Shares have lost 30% of their value since touching $459.75 on October 1. No particular news accounts for the action. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Abiomed continues slide, down 8%

via: SeekingAlpha at 2018-10-25 10:11:26:000

ABIOMED ( ABMD -7.7% ) is down in early trade. Shares have lost 30% of their value since touching $459.75 on October 1. No particular news accounts for the action. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Abiomed continues slide, down 8%

via: SeekingAlpha at 2018-10-25 10:11:26:000

ABIOMED ( ABMD -7.7% ) is down in early trade. Shares have lost 30% of their value since touching $459.75 on October 1. No particular news accounts for the action. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Down 15%+ In 15 Days

via: SeekingAlpha at 2018-10-22 14:35:40:000

October is still only a little more than 15 trading days old, but there are already 31 stocks in the S&P 500 that are down over 15% on the month. The table below lists each of those 31 names, and while it's not uncommon to see volatile stocks from the Technology or Consumer Discretionary s… read more...

Down 15%+ In 15 Days

via: SeekingAlpha at 2018-10-22 14:35:40:000

October is still only a little more than 15 trading days old, but there are already 31 stocks in the S&P 500 that are down over 15% on the month. The table below lists each of those 31 names, and while it's not uncommon to see volatile stocks from the Technology or Consumer Discretionary s… read more...

Down 15%+ In 15 Days

via: SeekingAlpha at 2018-10-22 14:35:40:000

October is still only a little more than 15 trading days old, but there are already 31 stocks in the S&P 500 that are down over 15% on the month. The table below lists each of those 31 names, and while it's not uncommon to see volatile stocks from the Technology or Consumer Discretionary s… read more...

Medical Device Business Is Good - Cramer's Lightning Round (10/9/18)

via: SeekingAlpha at 2018-10-10 06:54:00:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, October 9 . Bullish Calls Express Scripts (ESRX): They are merging with Cigna (CI). Cramer was bullish on Cigna after he interviewed the CEO. Abiomed (ABMD): The medical device business is go… read more...

Medical Device Business Is Good - Cramer's Lightning Round (10/9/18)

via: SeekingAlpha at 2018-10-10 06:54:00:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, October 9 . Bullish Calls Express Scripts (ESRX): They are merging with Cigna (CI). Cramer was bullish on Cigna after he interviewed the CEO. Abiomed (ABMD): The medical device business is go… read more...

Medical Device Business Is Good - Cramer's Lightning Round (10/9/18)

via: SeekingAlpha at 2018-10-10 06:54:00:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, October 9 . Bullish Calls Express Scripts (ESRX): They are merging with Cigna (CI). Cramer was bullish on Cigna after he interviewed the CEO. Abiomed (ABMD): The medical device business is go… read more...

Cramer's lightning round: Buy Express Scripts on its upcoming merger

via: CNBC at 2018-10-09 18:53:00:000

No summary available. read more...

Invesco S&P 500 Equal Weight ETF (RSP) September Summary

via: SeekingAlpha at 2018-10-09 11:15:45:000

September monthly performance was: +0.12% More news on: Invesco S&P 500 Equal Weight ETF, Edwards Lifesciences Corp, Alexion Pharmaceuticals, Inc., , Read more … read more...

Best And Worst-Performing Stocks In The S&P 500 Over The Last 20 Years And How They Have Performed In 2018

via: SeekingAlpha at 2018-09-27 09:32:18:000

Background Twenty years ago, on August 17th, 1998 to be precise, a financial crisis hit Russia ( RSX , ERUS ). It resulted in the Russian government and the Russian Central Bank devaluing the ruble and defaulting on its debt. The Russian crisis of 1998 happened only one year after the Asi… read more...

Best And Worst-Performing Stocks In The S&P 500 Over The Last 20 Years And How They Have Performed In 2018

via: SeekingAlpha at 2018-09-27 09:32:18:000

Background Twenty years ago, on August 17th, 1998 to be precise, a financial crisis hit Russia ( RSX , ERUS ). It resulted in the Russian government and the Russian Central Bank devaluing the ruble and defaulting on its debt. The Russian crisis of 1998 happened only one year after the Asi… read more...

Best And Worst-Performing Stocks In The S&P 500 Over The Last 20 Years And How They Have Performed In 2018

via: SeekingAlpha at 2018-09-27 09:32:18:000

Background Twenty years ago, on August 17th, 1998 to be precise, a financial crisis hit Russia ( RSX , ERUS ). It resulted in the Russian government and the Russian Central Bank devaluing the ruble and defaulting on its debt. The Russian crisis of 1998 happened only one year after the Asi… read more...

Abiomed up 8% on strong performance of Impella heart pumps

via: SeekingAlpha at 2018-09-24 13:29:30:000

Abiomed ( ABMD +8.1% ) is up average volume on the heels of its announcement of results from a new analysis of real-world data from its Impella Quality Database that showed a relative increase of 24% in average survival in acute myocardial infarction cardiogenic shock patients since Impe… read more...

Abiomed up 8% on strong performance of Impella heart pumps

via: SeekingAlpha at 2018-09-24 13:29:30:000

Abiomed ( ABMD +8.1% ) is up average volume on the heels of its announcement of results from a new analysis of real-world data from its Impella Quality Database that showed a relative increase of 24% in average survival in acute myocardial infarction cardiogenic shock patients since Impe… read more...

Abiomed up 8% on strong performance of Impella heart pumps

via: SeekingAlpha at 2018-09-24 13:29:30:000

Abiomed ( ABMD +8.1% ) is up average volume on the heels of its announcement of results from a new analysis of real-world data from its Impella Quality Database that showed a relative increase of 24% in average survival in acute myocardial infarction cardiogenic shock patients since Impe… read more...

The last time AMD shares surged like this, the stock crashed 96%

via: CNBC at 2018-09-17 07:41:00:000

No summary available. read more...

The last time AMD shares surged like this, the stock crashed 96%

via: CNBC at 2018-09-17 07:41:00:000

No summary available. read more...

The last time AMD shares surged like this, the stock crashed 96%

via: CNBC at 2018-09-17 07:41:00:000

No summary available. read more...

Corvia Medical's interatrial shunt shows positive effect in heart failure patients

via: SeekingAlpha at 2018-08-27 13:40:32:000

One-year follow-up data on privately held Corvia Medical's transcatheter InterAtrial Shunt Device (IASD) in heart failure patients showed a sustained benefit. The results, following the successful outcome of its REDUCE LAP-HF study, were presented at the ESC Congress in Munich. More ne… read more...

Corvia Medical's interatrial shunt shows positive effect in heart failure patients

via: SeekingAlpha at 2018-08-27 13:40:32:000

One-year follow-up data on privately held Corvia Medical's transcatheter InterAtrial Shunt Device (IASD) in heart failure patients showed a sustained benefit. The results, following the successful outcome of its REDUCE LAP-HF study, were presented at the ESC Congress in Munich. More ne… read more...

Corvia Medical's interatrial shunt shows positive effect in heart failure patients

via: SeekingAlpha at 2018-08-27 13:40:32:000

One-year follow-up data on privately held Corvia Medical's transcatheter InterAtrial Shunt Device (IASD) in heart failure patients showed a sustained benefit. The results, following the successful outcome of its REDUCE LAP-HF study, were presented at the ESC Congress in Munich. More ne… read more...

Advanced Micro Devices is up more than 145% this year and could have more room to run

via: CNBC at 2018-08-27 11:07:00:000

No summary available. read more...

Advanced Micro Devices is up more than 145% this year and could have more room to run

via: CNBC at 2018-08-27 11:07:00:000

No summary available. read more...

Advanced Micro Devices is up more than 145% this year and could have more room to run

via: CNBC at 2018-08-27 11:07:00:000

No summary available. read more...

Is ICU Medical A Better Bet Than ABIOMED?

via: SeekingAlpha at 2018-08-23 11:51:27:000

We look at many similar stocks And we see some interesting Reward~Risk trade-offs. Here are examples: Figure 1 Note: All materials from Blockdesk.com have been approved for use in this article. The tradeoffs here are between near-term upside price gains (green horizontal scale) see… read more...

Is ICU Medical A Better Bet Than ABIOMED?

via: SeekingAlpha at 2018-08-23 11:51:27:000

We look at many similar stocks And we see some interesting Reward~Risk trade-offs. Here are examples: Figure 1 Note: All materials from Blockdesk.com have been approved for use in this article. The tradeoffs here are between near-term upside price gains (green horizontal scale) see… read more...

Is ICU Medical A Better Bet Than ABIOMED?

via: SeekingAlpha at 2018-08-23 11:51:27:000

We look at many similar stocks And we see some interesting Reward~Risk trade-offs. Here are examples: Figure 1 Note: All materials from Blockdesk.com have been approved for use in this article. The tradeoffs here are between near-term upside price gains (green horizontal scale) see… read more...

Best And Worst S&P 500 Stocks On The Road To Nowhere

via: SeekingAlpha at 2018-08-22 02:33:39:000

Many are out making a big deal about the fact that the S&P 500 traded back to a new all-time high on Tuesday, but the reality is that the S&P 500 has been "dead money" for nearly seven months now. Along with the index itself being unchanged since late January, a very slight majority of… read more...

S&P 500: It's All In The Numbers And The Numbers Never Lie

via: SeekingAlpha at 2018-08-12 01:44:43:000

Introduction With 60% of 2018 already behind us and as the S&P 500 ( SPY ) is on the verge of making a new all time - we thought that it's as a good time as any to look at the YTD stats of the index. ^SPX data by YCharts S&P 500 Q2/2018 Y/Y Sales Growth by Sector Energ… read more...

S&P 500: It's All In The Numbers And The Numbers Never Lie

via: SeekingAlpha at 2018-08-12 01:44:43:000

Introduction With 60% of 2018 already behind us and as the S&P 500 ( SPY ) is on the verge of making a new all time - we thought that it's as a good time as any to look at the YTD stats of the index. ^SPX data by YCharts S&P 500 Q2/2018 Y/Y Sales Growth by Sector Energ… read more...

S&P 500: It's All In The Numbers And The Numbers Never Lie

via: SeekingAlpha at 2018-08-12 01:44:43:000

Introduction With 60% of 2018 already behind us and as the S&P 500 ( SPY ) is on the verge of making a new all time - we thought that it's as a good time as any to look at the YTD stats of the index. ^SPX data by YCharts S&P 500 Q2/2018 Y/Y Sales Growth by Sector Energ… read more...

Abiomed Is Another Intuitive Surgical In The Making - Is This Your Chance To Buy?

via: SeekingAlpha at 2018-08-06 13:18:56:000

Editor's note: Seeking Alpha is proud to welcome Rajesh Kumar as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Investment t… read more...

Abiomed Is Another Intuitive Surgical In The Making - Is This Your Chance To Buy?

via: SeekingAlpha at 2018-08-06 13:18:56:000

Editor's note: Seeking Alpha is proud to welcome Rajesh Kumar as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Investment t… read more...

Abiomed Is Another Intuitive Surgical In The Making - Is This Your Chance To Buy?

via: SeekingAlpha at 2018-08-06 13:18:56:000

Editor's note: Seeking Alpha is proud to welcome Rajesh Kumar as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Investment t… read more...

Medical Stock Investing: 2018 Update

via: SeekingAlpha at 2018-08-02 09:37:22:000

Given that we are just past the midpoint, I thought it would be a good time to review and update my 2018 forecast and stock picks. As I suggested, 2018 has turned out to be a stockpicker's year. The fundamentals of the US healthcare industry remain strong, as demographics, chronic disease prev… read more...

Medical Stock Investing: 2018 Update

via: SeekingAlpha at 2018-08-02 09:37:22:000

Given that we are just past the midpoint, I thought it would be a good time to review and update my 2018 forecast and stock picks. As I suggested, 2018 has turned out to be a stockpicker's year. The fundamentals of the US healthcare industry remain strong, as demographics, chronic disease prev… read more...

Medical Stock Investing: 2018 Update

via: SeekingAlpha at 2018-08-02 09:37:22:000

Given that we are just past the midpoint, I thought it would be a good time to review and update my 2018 forecast and stock picks. As I suggested, 2018 has turned out to be a stockpicker's year. The fundamentals of the US healthcare industry remain strong, as demographics, chronic disease prev… read more...

The Pullback Is Overdone. Abiomed Is Now A Strong Buy

via: SeekingAlpha at 2018-08-01 13:04:28:000

Abiomed ( ABMD ) remains relatively unknown among investors, yet it has a market capitalization of nearly $16B and is a leading provider of circulatory support medical devices. A steep drawdown following its recent quarterly earnings report has provided a great entry point for investors of thi… read more...

The Smart Way To Invest In Growth Stocks

via: SeekingAlpha at 2018-08-01 00:07:18:000

Growth investing is a massively popular strategy, and for good reasons. In essence, a stock is simply a share in the ownership of a business, and businesses with superior growth rates tend to generate higher returns for investors over the long term. Besides, many of the most profitable stocks … read more...

Med tech stocks mired in the red following Edwards, Mettler-Toledo results

via: SeekingAlpha at 2018-07-27 11:46:00:000

Medical device and equipment makers show relative weakness after large-cap peers Edwards Lifesciences ( EW -9.3% ) and Mettler-Toledo ( MTD -3.5% ) reported Q2 results ( I , II ) that disappointed investors. More news on: Edwards Lifesciences Corp, Mettler Toledo International Inc., A… read more...

Med tech stocks mired in the red following Edwards, Mettler-Toledo results

via: SeekingAlpha at 2018-07-27 11:46:00:000

Medical device and equipment makers show relative weakness after large-cap peers Edwards Lifesciences ( EW -9.3% ) and Mettler-Toledo ( MTD -3.5% ) reported Q2 results ( I , II ) that disappointed investors. More news on: Edwards Lifesciences Corp, Mettler Toledo International Inc., A… read more...

Med tech stocks mired in the red following Edwards, Mettler-Toledo results

via: SeekingAlpha at 2018-07-27 11:46:00:000

Medical device and equipment makers show relative weakness after large-cap peers Edwards Lifesciences ( EW -9.3% ) and Mettler-Toledo ( MTD -3.5% ) reported Q2 results ( I , II ) that disappointed investors. More news on: Edwards Lifesciences Corp, Mettler Toledo International Inc., A… read more...

Med tech stocks mired in the red following Edwards, Mettler-Toledo results

via: SeekingAlpha at 2018-07-27 11:46:00:000

Medical device and equipment makers show relative weakness after large-cap peers Edwards Lifesciences ( EW -9.3% ) and Mettler-Toledo ( MTD -3.5% ) reported Q2 results ( I , II ) that disappointed investors. More news on: Edwards Lifesciences Corp, Mettler Toledo International Inc., A… read more...

Med tech stocks mired in the red following Edwards, Mettler-Toledo results

via: SeekingAlpha at 2018-07-27 11:46:00:000

Medical device and equipment makers show relative weakness after large-cap peers Edwards Lifesciences ( EW -9.3% ) and Mettler-Toledo ( MTD -3.5% ) reported Q2 results ( I , II ) that disappointed investors. More news on: Edwards Lifesciences Corp, Mettler Toledo International Inc., A… read more...

ABIOMED, Inc. 2019 Q1 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-07-26 13:53:41:000

The following slide deck was published by ABIOMED, Inc. in conjunction with their 2019 Q1 earnings Read more … read more...

ABIOMED (ABMD) Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-07-26 12:11:06:000

ABIOMED, Inc. (ABMD) Q1 2019 Earnings Call July 26, 2018 8:00 am ET Executives Ingrid Goldberg - ABIOMED, Inc. Michael R. Minogue - ABIOMED, Inc. Todd A. Trapp - ABIOMED, Inc. Analysts Danielle Antalffy - Leerink Partners LLC Matthew O'Brien - Piper Jaffray & Co. Ch… read more...

Abiomed fiscal Q1 revenue up 36%; earnings up 141%; shares down 5% premarket

via: SeekingAlpha at 2018-07-26 08:25:18:000

Abiomed (NASDAQ: ABMD ) fiscal Q1 results ($M): Revenue: 180.0 (+35.8%). More news on: ABIOMED, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more … read more...

Abiomed beats by $1.13, beats on revenue

via: SeekingAlpha at 2018-07-26 07:09:36:000

Abiomed (NASDAQ: ABMD ): Q1 EPS of $1.95 beats by $1.13 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-07-25 17:30:13:000

AAL , AAN , AB , ABMD , ADNT , AGN , AIMC , ALK , ALKS , ALLE , ALLY , ALXN , APD , ARD , ASPS , AUO , AXE , AXTA , AZN , BANC , BAX , BC , BMS , BMY , BUD , BWA , CELG , CFR , CMCSA , CME , CMS , CNHI , COLB , COP , COR , COWN , CPG , CRI , CRR , CTS… read more...

Align Technology: Outstanding Revenue Growth At A Reasonable Multiple

via: SeekingAlpha at 2018-07-25 04:47:21:000

Align Technology ( ALGN ) is a $30.8B market cap medical device company that designs, manufactures, and markets an invisible orthodontic system called Invisalign, and scanning systems and services. The company does not pay a dividend. Approximately 89% of its revenue is g… read more...

Stay Away From Natural Gas Stocks - Cramer's Lightning Round (7/16/18)

via: SeekingAlpha at 2018-07-17 06:41:10:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, July 16. Bullish Calls Children's Place (PLCE): Don't judge based on one bad quarter. CEO Jane Elfers is doing a great job. It's too low and is worth buying. Dynavax Technologies (DVAX): The stoc… read more...

Stay Away From Natural Gas Stocks - Cramer's Lightning Round (7/16/18)

via: SeekingAlpha at 2018-07-17 06:41:10:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, July 16. Bullish Calls Children's Place (PLCE): Don't judge based on one bad quarter. CEO Jane Elfers is doing a great job. It's too low and is worth buying. Dynavax Technologies (DVAX): The stoc… read more...

Stay Away From Natural Gas Stocks - Cramer's Lightning Round (7/16/18)

via: SeekingAlpha at 2018-07-17 06:41:10:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, July 16. Bullish Calls Children's Place (PLCE): Don't judge based on one bad quarter. CEO Jane Elfers is doing a great job. It's too low and is worth buying. Dynavax Technologies (DVAX): The stoc… read more...

Cramer's lightning round: The best way to add gold to your portfolio

via: CNBC at 2018-07-16 18:50:00:000

No summary available. read more...

Stock Exchange: What Motivates Traders To Trade?

via: SeekingAlpha at 2018-07-13 07:03:53:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Motivates Traders To Trade?

via: SeekingAlpha at 2018-07-13 07:03:53:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Motivates Traders To Trade?

via: SeekingAlpha at 2018-07-13 07:03:53:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Motivates Traders To Trade?

via: SeekingAlpha at 2018-07-13 07:03:53:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

50 Best Performing S&P 500 Stocks In 1H18

via: SeekingAlpha at 2018-07-02 10:45:00:000

Charles Dickens' historical novel "A Tale of Two Cities" opens up with the famous phrase: "It was the best of times, it was the worst of times…". In a recently published article, I have already covered the worst of the first half of 2018, highlighting the 50 S&P 500 ( SPY ) constituents ... read more...

50 Best Performing S&P 500 Stocks In 1H18

via: SeekingAlpha at 2018-07-02 10:45:00:000

Charles Dickens' historical novel "A Tale of Two Cities" opens up with the famous phrase: "It was the best of times, it was the worst of times…". In a recently published article, I have already covered the worst of the first half of 2018, highlighting the 50 S&P 500 ( SPY ) constituents ... read more...

50 Best Performing S&P 500 Stocks In 1H18

via: SeekingAlpha at 2018-07-02 10:45:00:000

Charles Dickens' historical novel "A Tale of Two Cities" opens up with the famous phrase: "It was the best of times, it was the worst of times…". In a recently published article, I have already covered the worst of the first half of 2018, highlighting the 50 S&P 500 ( SPY ) constituents ... read more...

Project $1M: Mid-Year Review

via: SeekingAlpha at 2018-07-02 10:28:25:000

Project $1M is a concentrated portfolio that I am running with the aim of growing a ~$275k base into $1M over a 10-year period. I achieved a very satisfactory first-half performance for 2018, with the portfolio up 14% compared to 2.65% for the S&P 500. I compare the portfolio's performan… read more...

Project $1M: Mid-Year Review

via: SeekingAlpha at 2018-07-02 10:28:25:000

Project $1M is a concentrated portfolio that I am running with the aim of growing a ~$275k base into $1M over a 10-year period. I achieved a very satisfactory first-half performance for 2018, with the portfolio up 14% compared to 2.65% for the S&P 500. I compare the portfolio's performan… read more...

Project $1M: Mid-Year Review

via: SeekingAlpha at 2018-07-02 10:28:25:000

Project $1M is a concentrated portfolio that I am running with the aim of growing a ~$275k base into $1M over a 10-year period. I achieved a very satisfactory first-half performance for 2018, with the portfolio up 14% compared to 2.65% for the S&P 500. I compare the portfolio's performan… read more...

Tesla's nearly 2,000% gain from its IPO eight years ago shows power of disruption over profits

via: CNBC at 2018-06-29 13:08:00:000

No summary available. read more...

Tesla's nearly 2,000% gain from its IPO eight years ago shows power of disruption over profits

via: CNBC at 2018-06-29 13:08:00:000

No summary available. read more...

Tesla's nearly 2,000% gain from its IPO eight years ago shows power of disruption over profits

via: CNBC at 2018-06-29 13:08:00:000

No summary available. read more...

Impressive But Expensive Series - Volume 2: Abiomed

via: SeekingAlpha at 2018-06-29 11:47:26:000

Investment Thesis Abiomed (ABMD) essentially has a monopoly on its market, incredible financials, and strong competitive advantages but the valuation looks a little too high right now. ABMD data by YCharts What It Sells Surprise! This article isn't about a "technology" compan… read more...

Impressive But Expensive Series - Volume 2: Abiomed

via: SeekingAlpha at 2018-06-29 11:47:26:000

Investment Thesis Abiomed (ABMD) essentially has a monopoly on its market, incredible financials, and strong competitive advantages but the valuation looks a little too high right now. ABMD data by YCharts What It Sells Surprise! This article isn't about a "technology" compan… read more...

Impressive But Expensive Series - Volume 2: Abiomed

via: SeekingAlpha at 2018-06-29 11:47:26:000

Investment Thesis Abiomed (ABMD) essentially has a monopoly on its market, incredible financials, and strong competitive advantages but the valuation looks a little too high right now. ABMD data by YCharts What It Sells Surprise! This article isn't about a "technology" compan… read more...

Stock Exchange: How Do You React To A Tough Day In The Market?

via: SeekingAlpha at 2018-06-29 08:31:11:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: How Do You React To A Tough Day In The Market?

via: SeekingAlpha at 2018-06-29 08:31:11:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: How Do You React To A Tough Day In The Market?

via: SeekingAlpha at 2018-06-29 08:31:11:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Is Your Trading Personality?

via: SeekingAlpha at 2018-06-22 05:50:41:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Is Your Trading Personality?

via: SeekingAlpha at 2018-06-22 05:50:41:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Is Your Trading Personality?

via: SeekingAlpha at 2018-06-22 05:50:41:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Is Your Trading Personality?

via: SeekingAlpha at 2018-06-22 05:50:41:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: What Is Your Trading Personality?

via: SeekingAlpha at 2018-06-22 05:50:41:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Discovery Is Undervalued - Cramer's Lightning Round (6/11/18)

via: SeekingAlpha at 2018-06-12 06:53:07:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, June 11. Bullish Calls Discovery (DISCA): Yes, their content is undervalued. Cramer thinks both Discovery and Viacom (VIA) are undervalued. Abiomed (ABMD): Cramer has been a fan for a long time. … read more...

Discovery Is Undervalued - Cramer's Lightning Round (6/11/18)

via: SeekingAlpha at 2018-06-12 06:53:07:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, June 11. Bullish Calls Discovery (DISCA): Yes, their content is undervalued. Cramer thinks both Discovery and Viacom (VIA) are undervalued. Abiomed (ABMD): Cramer has been a fan for a long time. … read more...

Discovery Is Undervalued - Cramer's Lightning Round (6/11/18)

via: SeekingAlpha at 2018-06-12 06:53:07:000

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, June 11. Bullish Calls Discovery (DISCA): Yes, their content is undervalued. Cramer thinks both Discovery and Viacom (VIA) are undervalued. Abiomed (ABMD): Cramer has been a fan for a long time. … read more...

Cramer's lightning round: Both Discovery and Viacom could be undervalued

via: CNBC at 2018-06-11 18:50:00:000

No summary available. read more...

Stock Exchange: Do You Start The Day With A Trading Plan?

via: SeekingAlpha at 2018-06-08 07:49:29:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: Do You Start The Day With A Trading Plan?

via: SeekingAlpha at 2018-06-08 07:49:29:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: Do You Start The Day With A Trading Plan?

via: SeekingAlpha at 2018-06-08 07:49:29:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Stock Exchange: Do You Start The Day With A Trading Plan?

via: SeekingAlpha at 2018-06-08 07:49:29:000

The Stock Exchange is all about trading. Each week we do the following: Discuss an important issue for traders; highlight several technical trading methods, including current ideas; feature advice from top traders and writers; and, provide a few (minority) reactions from fundamenta… read more...

Abiomed Is All Set For A Continued Upward Ride In 2018

via: SeekingAlpha at 2018-06-06 09:12:10:000

With Abiomed ( ABMD ) getting entry in the coveted S&P 500 , I feel that there can be no better time to pick up this stock in 2018. The company has already guided for a very strong FY 19 , with revenues expected to grow a whopping 25-30% year over year and reach $740-770 million. Then, w… read more...

Abiomed Is All Set For A Continued Upward Ride In 2018

via: SeekingAlpha at 2018-06-06 09:12:10:000

With Abiomed ( ABMD ) getting entry in the coveted S&P 500 , I feel that there can be no better time to pick up this stock in 2018. The company has already guided for a very strong FY 19 , with revenues expected to grow a whopping 25-30% year over year and reach $740-770 million. Then, w… read more...

By The Numbers: Consistent Growth Leaders With Strong Fundamentals

via: SeekingAlpha at 2018-06-05 09:12:26:000

Investing in growth stocks can generate outstanding returns over the long term. However, growth stocks are also particularly volatile, and companies with superior growth can many times carry above-average risks too. The key, like usually happens, is separating the fundamentally sound companies… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

New And Old Investing Stories To Be Told

via: SeekingAlpha at 2018-06-01 11:30:00:000

It seems like every voice has been heard from, that every story has been told. The internet of 2018 can be a fatigue-inducing environment, and that's no different in the investing space. We're well past the time earlier in the decade where people were still wary of the markets, where a new sho… read more...

ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

via: PR Newswire at 2018-05-25 17:55:00:000

NEW YORK , May 25, 2018 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent ABIOMED Inc. (NASD: ABMD) will replace Wyndham Worldwide Corp. (NYSE: WYN) in the S&am… read more...

ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

via: PR Newswire at 2018-05-25 17:55:00:000

NEW YORK , May 25, 2018 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent ABIOMED Inc. (NASD: ABMD) will replace Wyndham Worldwide Corp. (NYSE: WYN) in the S&am… read more...

ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

via: PR Newswire at 2018-05-25 17:55:00:000

NEW YORK , May 25, 2018 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent ABIOMED Inc. (NASD: ABMD) will replace Wyndham Worldwide Corp. (NYSE: WYN) in the S&am… read more...

ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

via: PR Newswire at 2018-05-25 17:55:00:000

NEW YORK , May 25, 2018 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent ABIOMED Inc. (NASD: ABMD) will replace Wyndham Worldwide Corp. (NYSE: WYN) in the S&am… read more...

ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

via: PR Newswire at 2018-05-25 17:55:00:000

NEW YORK , May 25, 2018 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent ABIOMED Inc. (NASD: ABMD) will replace Wyndham Worldwide Corp. (NYSE: WYN) in the S&am… read more...

ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

via: PR Newswire at 2018-05-25 17:55:00:000

NEW YORK , May 25, 2018 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent ABIOMED Inc. (NASD: ABMD) will replace Wyndham Worldwide Corp. (NYSE: WYN) in the S&am… read more...

PRAH +3% on MidCap 400 move; ABMD to S&P 500

via: SeekingAlpha at 2018-05-25 17:37:05:000

ABIOMED (NASDAQ: ABMD ) is heading into the S&P 500 as part of a series of index changes announced by Standard & Poor's. More news on: ABIOMED, Inc., Wyndham Worldwide Corporation, PRA Health Sciences, Healthcare stocks news, Tech stocks news, Consumer stocks news, Stocks on the … read more...

PRAH +3% on MidCap 400 move; ABMD to S&P 500

via: SeekingAlpha at 2018-05-25 17:37:05:000

ABIOMED (NASDAQ: ABMD ) is heading into the S&P 500 as part of a series of index changes announced by Standard & Poor's. More news on: ABIOMED, Inc., Wyndham Worldwide Corporation, PRA Health Sciences, Healthcare stocks news, Tech stocks news, Consumer stocks news, Stocks on the … read more...

PRAH +3% on MidCap 400 move; ABMD to S&P 500

via: SeekingAlpha at 2018-05-25 17:37:05:000

ABIOMED (NASDAQ: ABMD ) is heading into the S&P 500 as part of a series of index changes announced by Standard & Poor's. More news on: ABIOMED, Inc., Wyndham Worldwide Corporation, PRA Health Sciences, Healthcare stocks news, Tech stocks news, Consumer stocks news, Stocks on the … read more...

PRAH +3% on MidCap 400 move; ABMD to S&P 500

via: SeekingAlpha at 2018-05-25 17:37:05:000

ABIOMED (NASDAQ: ABMD ) is heading into the S&P 500 as part of a series of index changes announced by Standard & Poor's. More news on: ABIOMED, Inc., Wyndham Worldwide Corporation, PRA Health Sciences, Healthcare stocks news, Tech stocks news, Consumer stocks news, Stocks on the … read more...

PRAH +3% on MidCap 400 move; ABMD to S&P 500

via: SeekingAlpha at 2018-05-25 17:37:05:000

ABIOMED (NASDAQ: ABMD ) is heading into the S&P 500 as part of a series of index changes announced by Standard & Poor's. More news on: ABIOMED, Inc., Wyndham Worldwide Corporation, PRA Health Sciences, Healthcare stocks news, Tech stocks news, Consumer stocks news, Stocks on the … read more...

PRAH +3% on MidCap 400 move; ABMD to S&P 500

via: SeekingAlpha at 2018-05-25 17:37:05:000

ABIOMED (NASDAQ: ABMD ) is heading into the S&P 500 as part of a series of index changes announced by Standard & Poor's. More news on: ABIOMED, Inc., Wyndham Worldwide Corporation, PRA Health Sciences, Healthcare stocks news, Tech stocks news, Consumer stocks news, Stocks on the … read more...

A Quantitative System To Invest In Quality Stocks

via: SeekingAlpha at 2018-05-21 11:57:48:000

Most investors would agree on the fact that investing in high quality stocks can lead to superior returns and lower risks over the long term. However, the concept of quality can be hard to define and evaluate. That notwithstanding, quality can be measured numerically, and business profitabil… read more...

A Quantitative System To Invest In Quality Stocks

via: SeekingAlpha at 2018-05-21 11:57:48:000

Most investors would agree on the fact that investing in high quality stocks can lead to superior returns and lower risks over the long term. However, the concept of quality can be hard to define and evaluate. That notwithstanding, quality can be measured numerically, and business profitabil… read more...

A Quantitative System To Invest In Quality Stocks

via: SeekingAlpha at 2018-05-21 11:57:48:000

Most investors would agree on the fact that investing in high quality stocks can lead to superior returns and lower risks over the long term. However, the concept of quality can be hard to define and evaluate. That notwithstanding, quality can be measured numerically, and business profitabil… read more...

A Quantitative System To Invest In Quality Stocks

via: SeekingAlpha at 2018-05-21 11:57:48:000

Most investors would agree on the fact that investing in high quality stocks can lead to superior returns and lower risks over the long term. However, the concept of quality can be hard to define and evaluate. That notwithstanding, quality can be measured numerically, and business profitabil… read more...

A Quantitative System To Invest In Quality Stocks

via: SeekingAlpha at 2018-05-21 11:57:48:000

Most investors would agree on the fact that investing in high quality stocks can lead to superior returns and lower risks over the long term. However, the concept of quality can be hard to define and evaluate. That notwithstanding, quality can be measured numerically, and business profitabil… read more...

A Quantitative System To Invest In Quality Stocks

via: SeekingAlpha at 2018-05-21 11:57:48:000

Most investors would agree on the fact that investing in high quality stocks can lead to superior returns and lower risks over the long term. However, the concept of quality can be hard to define and evaluate. That notwithstanding, quality can be measured numerically, and business profitabil… read more...

A Quantitative System To Invest In Quality Stocks

via: SeekingAlpha at 2018-05-21 11:57:48:000

Most investors would agree on the fact that investing in high quality stocks can lead to superior returns and lower risks over the long term. However, the concept of quality can be hard to define and evaluate. That notwithstanding, quality can be measured numerically, and business profitabil… read more...

Bulletproof Investing Performance Update: Week 23

via: SeekingAlpha at 2018-05-04 03:15:33:000

Safety First: NASCAR driver Johanna Long and her helmet (Credit: Gearheads ) Bulletproof Investing: Week 23 Performance Each week since the beginning of June, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is … read more...

Bulletproof Investing Performance Update: Week 23

via: SeekingAlpha at 2018-05-04 03:15:33:000

Safety First: NASCAR driver Johanna Long and her helmet (Credit: Gearheads ) Bulletproof Investing: Week 23 Performance Each week since the beginning of June, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is … read more...

ABIOMED (ABMD) Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-03 13:27:08:000

ABIOMED, Inc. (ABMD) Q4 2018 Earnings Call May 03, 2018 8:00 am ET Executives Ingrid Goldberg - ABIOMED, Inc. Michael R. Minogue - ABIOMED, Inc. Todd A. Trapp - ABIOMED, Inc. Analysts Bruce M. Nudell - SunTrust Robinson Humphrey, Inc. Raj Denhoy - Jefferies LLC Chris Pa… read more...

ABIOMED (ABMD) Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-03 13:27:08:000

ABIOMED, Inc. (ABMD) Q4 2018 Earnings Call May 03, 2018 8:00 am ET Executives Ingrid Goldberg - ABIOMED, Inc. Michael R. Minogue - ABIOMED, Inc. Todd A. Trapp - ABIOMED, Inc. Analysts Bruce M. Nudell - SunTrust Robinson Humphrey, Inc. Raj Denhoy - Jefferies LLC Chris Pa… read more...

Abiomed Q4 revenues up 40%; updates guidance

via: SeekingAlpha at 2018-05-03 09:28:31:000

Abiomed ( ABMD ) Q4 results : Revenues: $174.4M (+39.9%); Operating Income: $47.6M (+64.1%); Net Income: $36.8M; EPS: $0.80; Quick Assets: $362.2M (+57.5%). More news on: ABIOMED, Inc., Healthcare stocks news, Earnings news and commentary, Read more … read more...

Abiomed Q4 revenues up 40%; updates guidance

via: SeekingAlpha at 2018-05-03 09:28:31:000

Abiomed ( ABMD ) Q4 results : Revenues: $174.4M (+39.9%); Operating Income: $47.6M (+64.1%); Net Income: $36.8M; EPS: $0.80; Quick Assets: $362.2M (+57.5%). More news on: ABIOMED, Inc., Healthcare stocks news, Earnings news and commentary, Read more … read more...

Abiomed beats by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-03 07:14:08:000

Abiomed (NASDAQ: ABMD ): Q4 EPS of $0.80 beats by $0.16 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Abiomed beats by $0.16, beats on revenue

via: SeekingAlpha at 2018-05-03 07:14:08:000

Abiomed (NASDAQ: ABMD ): Q4 EPS of $0.80 beats by $0.16 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-05-02 17:30:55:000

AAON , AAWW , ABMD , ADNT , AER , AMAG , APLP , APO , APRN , ARES , AROC , ARW , AVP , AYR , BCE , BDX , BERY , BLL , BSIG , CAH , CBM , CCOI , CEIX , CFX , CHD , CI , CIM , CJ , CNQ , CNSL , CNX , CNXM , COT , CPG , DWDP , EEX , EPC , ERF , FMS , FMS… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-05-02 17:30:55:000

AAON , AAWW , ABMD , ADNT , AER , AMAG , APLP , APO , APRN , ARES , AROC , ARW , AVP , AYR , BCE , BDX , BERY , BLL , BSIG , CAH , CBM , CCOI , CEIX , CFX , CHD , CI , CIM , CJ , CNQ , CNSL , CNX , CNXM , COT , CPG , DWDP , EEX , EPC , ERF , FMS , FMS… read more...

Abiomed's Impella 5.5 heart pump CE Mark'd

via: SeekingAlpha at 2018-04-04 09:16:32:000

Abiomed (NASDAQ: ABMD ) announces that its Impella 5.5 heart pump now has CE Mark certification. The first patient has already been treated in Germany. More news on: ABIOMED, Inc., Healthcare stocks news, Read more … read more...

Abiomed's Impella 5.5 heart pump CE Mark'd

via: SeekingAlpha at 2018-04-04 09:16:32:000

Abiomed (NASDAQ: ABMD ) announces that its Impella 5.5 heart pump now has CE Mark certification. The first patient has already been treated in Germany. More news on: ABIOMED, Inc., Healthcare stocks news, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-04-04 08:26:59:000

Dexcom (NASDAQ: DXCM ) initiated with a Sell rating and $57 (24% downside risk) price target at Goldman Sachs. Initiated with Neutral rating at Guggenheim. Shares down 5% premarket. More news on: DexCom, Inc., NuVasive, Inc., Nevro, Healthcare stocks news, Stocks on the move, ,… read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-04-04 08:26:59:000

Dexcom (NASDAQ: DXCM ) initiated with a Sell rating and $57 (24% downside risk) price target at Goldman Sachs. Initiated with Neutral rating at Guggenheim. Shares down 5% premarket. More news on: DexCom, Inc., NuVasive, Inc., Nevro, Healthcare stocks news, Stocks on the move, ,… read more...

Your Daily Pharma Scoop: MediciNova Makes A Strong Comeback, Alkermes' Setback, BioLife Preliminary Q1 Results

via: SeekingAlpha at 2018-04-03 11:48:30:000

After a sell-off last week, MediciNova (NASDAQ: MNOV ) shares have bounced back sharply in trading today as the company announced that it is terminating a phase 2 study of MN-001 in NASH and NAFLD with hypertriglyceridemia early based on the significant positive results from an interim analysi… read more...

Your Daily Pharma Scoop: MediciNova Makes A Strong Comeback, Alkermes' Setback, BioLife Preliminary Q1 Results

via: SeekingAlpha at 2018-04-03 11:48:30:000

After a sell-off last week, MediciNova (NASDAQ: MNOV ) shares have bounced back sharply in trading today as the company announced that it is terminating a phase 2 study of MN-001 in NASH and NAFLD with hypertriglyceridemia early based on the significant positive results from an interim analysi… read more...

What's Cheap? A Factor Perspective

via: SeekingAlpha at 2018-03-25 06:48:36:000

There are a hundred ways to evaluate whether an investment is cheap - discounted cash flows, competitor multiples, mean reversion, multiple of projected earnings - the list goes on…and on. To each his own on what is the "best" valuation methodology, but suffice it to say that the persistent ... read more...

What's Cheap? A Factor Perspective

via: SeekingAlpha at 2018-03-25 06:48:36:000

There are a hundred ways to evaluate whether an investment is cheap - discounted cash flows, competitor multiples, mean reversion, multiple of projected earnings - the list goes on…and on. To each his own on what is the "best" valuation methodology, but suffice it to say that the persistent ... read more...

By The Numbers: Growth Stocks With Superior Relative Strength

via: SeekingAlpha at 2018-03-14 11:32:02:000

Investing in growth stocks is not easy at all, and high-growth companies usually carry above-average risk and volatility. However, focusing on companies with superior top-line performance can also be enormously profitable when done right. The following paragraphs are introducing a quantitati… read more...

By The Numbers: Growth Stocks With Superior Relative Strength

via: SeekingAlpha at 2018-03-14 11:32:02:000

Investing in growth stocks is not easy at all, and high-growth companies usually carry above-average risk and volatility. However, focusing on companies with superior top-line performance can also be enormously profitable when done right. The following paragraphs are introducing a quantitati… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

via: SeekingAlpha at 2018-02-15 08:01:00:000

Analysis of top Seeking Alpha coverage: Achaogen Today we will focus on Achaogen ( AKAO ), which got a slight boost after Tetraphase Pharmas ( TTPH ) drug failed to beat ertapenem in a late-stage cUTI study. AKAO shares were up more than 1% in early trading on Wednesday. Achaoge… read more...

FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up 3%

via: SeekingAlpha at 2018-02-14 10:10:43:000

The FDA approves the use of Abiomed's ( ABMD +2.8% ) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary inter… read more...

FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up 3%

via: SeekingAlpha at 2018-02-14 10:10:43:000

The FDA approves the use of Abiomed's ( ABMD +2.8% ) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary inter… read more...

FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up 3%

via: SeekingAlpha at 2018-02-14 10:10:43:000

The FDA approves the use of Abiomed's ( ABMD +2.8% ) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary inter… read more...

FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up 3%

via: SeekingAlpha at 2018-02-14 10:10:43:000

The FDA approves the use of Abiomed's ( ABMD +2.8% ) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary inter… read more...

FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up 3%

via: SeekingAlpha at 2018-02-14 10:10:43:000

The FDA approves the use of Abiomed's ( ABMD +2.8% ) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary inter… read more...

FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up 3%

via: SeekingAlpha at 2018-02-14 10:10:43:000

The FDA approves the use of Abiomed's ( ABMD +2.8% ) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary inter… read more...

FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up 3%

via: SeekingAlpha at 2018-02-14 10:10:43:000

The FDA approves the use of Abiomed's ( ABMD +2.8% ) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary inter… read more...

Your Daily Pharma Scoop: Synergy Update, Vertex Results, Affimed Data

via: SeekingAlpha at 2018-02-02 08:00:00:000

Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today we will discuss the update from Synergy Pharmaceuticals ( SGYP ), which has ended some of the recent uncertainty. Having said that, the news has not really given a boost to SGYP shares. This is because the future diluti… read more...

Your Daily Pharma Scoop: Synergy Update, Vertex Results, Affimed Data

via: SeekingAlpha at 2018-02-02 08:00:00:000

Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today we will discuss the update from Synergy Pharmaceuticals ( SGYP ), which has ended some of the recent uncertainty. Having said that, the news has not really given a boost to SGYP shares. This is because the future diluti… read more...

Your Daily Pharma Scoop: Synergy Update, Vertex Results, Affimed Data

via: SeekingAlpha at 2018-02-02 08:00:00:000

Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today we will discuss the update from Synergy Pharmaceuticals ( SGYP ), which has ended some of the recent uncertainty. Having said that, the news has not really given a boost to SGYP shares. This is because the future diluti… read more...

Your Daily Pharma Scoop: Synergy Update, Vertex Results, Affimed Data

via: SeekingAlpha at 2018-02-02 08:00:00:000

Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today we will discuss the update from Synergy Pharmaceuticals ( SGYP ), which has ended some of the recent uncertainty. Having said that, the news has not really given a boost to SGYP shares. This is because the future diluti… read more...

Your Daily Pharma Scoop: Synergy Update, Vertex Results, Affimed Data

via: SeekingAlpha at 2018-02-02 08:00:00:000

Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today we will discuss the update from Synergy Pharmaceuticals ( SGYP ), which has ended some of the recent uncertainty. Having said that, the news has not really given a boost to SGYP shares. This is because the future diluti… read more...

ABIOMED's (ABMD) CEO Michael Minogue on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 14:40:08:000

ABIOMED, Inc. (ABMD) Q3 2018 Earnings Conference Call February 01, 2018 08:00 AM ET Executives Ingrid Goldberg - Director of Investor Relations Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Christopher Pasquale - Guggen… read more...

ABIOMED's (ABMD) CEO Michael Minogue on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 14:40:08:000

ABIOMED, Inc. (ABMD) Q3 2018 Earnings Conference Call February 01, 2018 08:00 AM ET Executives Ingrid Goldberg - Director of Investor Relations Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Christopher Pasquale - Guggen… read more...

ABIOMED's (ABMD) CEO Michael Minogue on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 14:40:08:000

ABIOMED, Inc. (ABMD) Q3 2018 Earnings Conference Call February 01, 2018 08:00 AM ET Executives Ingrid Goldberg - Director of Investor Relations Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Christopher Pasquale - Guggen… read more...

Abiomed Q3 revenues up 34%; updates guidance

via: SeekingAlpha at 2018-02-01 08:59:42:000

Abiomed ( ABMD ) Q3 results : Revenues: $154M (+34.3%); Operating Income: $44.8M (+76.4%); Net Income: $13.4M (-13.0%); EPS: $0.29 (-14.7%); Non-GAAP EPS: $0.70; Quick Assets: $301.3M (+31.1%). More news on: ABIOMED, Inc., Healthcare stocks news, Earnings news and commentary, Read mor… read more...

Abiomed Q3 revenues up 34%; updates guidance

via: SeekingAlpha at 2018-02-01 08:59:42:000

Abiomed ( ABMD ) Q3 results : Revenues: $154M (+34.3%); Operating Income: $44.8M (+76.4%); Net Income: $13.4M (-13.0%); EPS: $0.29 (-14.7%); Non-GAAP EPS: $0.70; Quick Assets: $301.3M (+31.1%). More news on: ABIOMED, Inc., Healthcare stocks news, Earnings news and commentary, Read mor… read more...

Abiomed Q3 revenues up 34%; updates guidance

via: SeekingAlpha at 2018-02-01 08:59:42:000

Abiomed ( ABMD ) Q3 results : Revenues: $154M (+34.3%); Operating Income: $44.8M (+76.4%); Net Income: $13.4M (-13.0%); EPS: $0.29 (-14.7%); Non-GAAP EPS: $0.70; Quick Assets: $301.3M (+31.1%). More news on: ABIOMED, Inc., Healthcare stocks news, Earnings news and commentary, Read mor… read more...

ABIOMED, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-02-01 08:54:36:000

The following slide deck was published by ABIOMED, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

ABIOMED, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-02-01 08:54:36:000

The following slide deck was published by ABIOMED, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

ABIOMED, Inc. 2018 Q3 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-02-01 08:54:36:000

The following slide deck was published by ABIOMED, Inc. in conjunction with their 2018 Q3 earnings Read more … read more...

Abiomed beats by $0.19, beats on revenue

via: SeekingAlpha at 2018-02-01 07:03:06:000

Abiomed (NASDAQ: ABMD ): Q3 EPS of $0.70 beats by $0.19 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Abiomed beats by $0.19, beats on revenue

via: SeekingAlpha at 2018-02-01 07:03:06:000

Abiomed (NASDAQ: ABMD ): Q3 EPS of $0.70 beats by $0.19 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Abiomed beats by $0.19, beats on revenue

via: SeekingAlpha at 2018-02-01 07:03:06:000

Abiomed (NASDAQ: ABMD ): Q3 EPS of $0.70 beats by $0.19 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-01-31 17:30:11:000

ABMD , AME , AN , APO , APTV , BABA , BAX , BC , BDC , BMS , BNCL , BSX , BX , CI , CME , COP , CRS , DGX , DWDP , ETN , FCFS , HSY , IDXX , INGR , IP , KELYA , KEM , LAZ , LPG , LQDT , MA , MCK , MDC , MHO , MIXT , MMC , MMP , MO , MPC , MPLX , MSCI… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-01-31 17:30:11:000

ABMD , AME , AN , APO , APTV , BABA , BAX , BC , BDC , BMS , BNCL , BSX , BX , CI , CME , COP , CRS , DGX , DWDP , ETN , FCFS , HSY , IDXX , INGR , IP , KELYA , KEM , LAZ , LPG , LQDT , MA , MCK , MDC , MHO , MIXT , MMC , MMP , MO , MPC , MPLX , MSCI… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2018-01-31 17:30:11:000

ABMD , AME , AN , APO , APTV , BABA , BAX , BC , BDC , BMS , BNCL , BSX , BX , CI , CME , COP , CRS , DGX , DWDP , ETN , FCFS , HSY , IDXX , INGR , IP , KELYA , KEM , LAZ , LPG , LQDT , MA , MCK , MDC , MHO , MIXT , MMC , MMP , MO , MPC , MPLX , MSCI… read more...

Cash Kings: AbbVie, Abiomed, And Blackrock

via: SeekingAlpha at 2018-01-19 20:03:26:000

I wanted to put together a quick summary of three big winners in 2017. Being new to Seeking Alpha, 2017 was a strong year for Fusion Stocks and overall Fusion Trading. "Fusion Trading" strategies blend fundamental "factors" with technical timing and behavioral finance. For starters, I approa… read more...

Cash Kings: AbbVie, Abiomed, And Blackrock

via: SeekingAlpha at 2018-01-19 20:03:26:000

I wanted to put together a quick summary of three big winners in 2017. Being new to Seeking Alpha, 2017 was a strong year for Fusion Stocks and overall Fusion Trading. "Fusion Trading" strategies blend fundamental "factors" with technical timing and behavioral finance. For starters, I approa… read more...

Cash Kings: AbbVie, Abiomed, And Blackrock

via: SeekingAlpha at 2018-01-19 20:03:26:000

I wanted to put together a quick summary of three big winners in 2017. Being new to Seeking Alpha, 2017 was a strong year for Fusion Stocks and overall Fusion Trading. "Fusion Trading" strategies blend fundamental "factors" with technical timing and behavioral finance. For starters, I approa… read more...

Cash Kings: AbbVie, Abiomed, And Blackrock

via: SeekingAlpha at 2018-01-19 20:03:26:000

I wanted to put together a quick summary of three big winners in 2017. Being new to Seeking Alpha, 2017 was a strong year for Fusion Stocks and overall Fusion Trading. "Fusion Trading" strategies blend fundamental "factors" with technical timing and behavioral finance. For starters, I approa… read more...

Cash Kings: AbbVie, Abiomed, And Blackrock

via: SeekingAlpha at 2018-01-19 20:03:26:000

I wanted to put together a quick summary of three big winners in 2017. Being new to Seeking Alpha, 2017 was a strong year for Fusion Stocks and overall Fusion Trading. "Fusion Trading" strategies blend fundamental "factors" with technical timing and behavioral finance. For starters, I approa… read more...

Investment Ideas In Quality Stocks

via: SeekingAlpha at 2018-01-14 12:38:13:000

Most investors would agree on the fact that quality is a powerful return driver for stocks. However, the concept of quality can be hard to define. The idea certainly includes many soft variables such as the companys competitive advantages and the track record of the management team, am… read more...

Investment Ideas In Quality Stocks

via: SeekingAlpha at 2018-01-14 12:38:13:000

Most investors would agree on the fact that quality is a powerful return driver for stocks. However, the concept of quality can be hard to define. The idea certainly includes many soft variables such as the companys competitive advantages and the track record of the management team, am… read more...

Investment Ideas In Quality Stocks

via: SeekingAlpha at 2018-01-14 12:38:13:000

Most investors would agree on the fact that quality is a powerful return driver for stocks. However, the concept of quality can be hard to define. The idea certainly includes many soft variables such as the companys competitive advantages and the track record of the management team, am… read more...

Investment Ideas In Quality Stocks

via: SeekingAlpha at 2018-01-14 12:38:13:000

Most investors would agree on the fact that quality is a powerful return driver for stocks. However, the concept of quality can be hard to define. The idea certainly includes many soft variables such as the companys competitive advantages and the track record of the management team, am… read more...

Investment Ideas In Quality Stocks

via: SeekingAlpha at 2018-01-14 12:38:13:000

Most investors would agree on the fact that quality is a powerful return driver for stocks. However, the concept of quality can be hard to define. The idea certainly includes many soft variables such as the companys competitive advantages and the track record of the management team, am… read more...

Abiomed (ABMD) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-01-09 13:54:26:000

The following slide deck was published by ABIOMED, Inc. in conjunction with this Read more … read more...

Abiomed (ABMD) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-01-09 13:54:26:000

The following slide deck was published by ABIOMED, Inc. in conjunction with this Read more … read more...

Abiomed (ABMD) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-01-09 13:54:26:000

The following slide deck was published by ABIOMED, Inc. in conjunction with this Read more … read more...

Abiomed (ABMD) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-01-09 13:54:26:000

The following slide deck was published by ABIOMED, Inc. in conjunction with this Read more … read more...

Abiomed (ABMD) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-01-09 13:54:26:000

The following slide deck was published by ABIOMED, Inc. in conjunction with this Read more … read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Teva Q3 Results, Boost For RedHill, Clovis Reports Rubraca Sales

via: SeekingAlpha at 2017-11-02 09:42:55:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about chan… read more...

Your Daily Pharma Scoop: Teva Q3 Results, Boost For RedHill, Clovis Reports Rubraca Sales

via: SeekingAlpha at 2017-11-02 09:42:55:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about chan… read more...

Your Daily Pharma Scoop: Teva Q3 Results, Boost For RedHill, Clovis Reports Rubraca Sales

via: SeekingAlpha at 2017-11-02 09:42:55:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about chan… read more...

Your Daily Pharma Scoop: Teva Q3 Results, Boost For RedHill, Clovis Reports Rubraca Sales

via: SeekingAlpha at 2017-11-02 09:42:55:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about chan… read more...

Your Daily Pharma Scoop: Teva Q3 Results, Boost For RedHill, Clovis Reports Rubraca Sales

via: SeekingAlpha at 2017-11-02 09:42:55:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about chan… read more...

Abiomed's big run continues after investor meeting; shares up 6.9%

via: SeekingAlpha at 2017-10-31 15:00:55:000

The company yesterday held an investor meeting at theTranscatheter Cardiovascular Therapeutics conference. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Abiomed's big run continues after investor meeting; shares up 6.9%

via: SeekingAlpha at 2017-10-31 15:00:55:000

The company yesterday held an investor meeting at theTranscatheter Cardiovascular Therapeutics conference. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Abiomed's big run continues after investor meeting; shares up 6.9%

via: SeekingAlpha at 2017-10-31 15:00:55:000

The company yesterday held an investor meeting at theTranscatheter Cardiovascular Therapeutics conference. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Abiomed's big run continues after investor meeting; shares up 6.9%

via: SeekingAlpha at 2017-10-31 15:00:55:000

The company yesterday held an investor meeting at theTranscatheter Cardiovascular Therapeutics conference. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Abiomed's big run continues after investor meeting; shares up 6.9%

via: SeekingAlpha at 2017-10-31 15:00:55:000

The company yesterday held an investor meeting at theTranscatheter Cardiovascular Therapeutics conference. More news on: ABIOMED, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

ABIOMED's (ABMD) CEO Mike Minogue on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-10-28 10:25:09:000

ABIOMED, Inc. (ABMD) Q2 2018 Earnings Conference Call October 26, 2017 08:00 AM ET Executives Steve McEvoy - Vice President and General Counsel Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Bruce Nudell - SunTrust Robin… read more...

ABIOMED's (ABMD) CEO Mike Minogue on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-10-28 10:25:09:000

ABIOMED, Inc. (ABMD) Q2 2018 Earnings Conference Call October 26, 2017 08:00 AM ET Executives Steve McEvoy - Vice President and General Counsel Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Bruce Nudell - SunTrust Robin… read more...

ABIOMED's (ABMD) CEO Mike Minogue on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-10-28 10:25:09:000

ABIOMED, Inc. (ABMD) Q2 2018 Earnings Conference Call October 26, 2017 08:00 AM ET Executives Steve McEvoy - Vice President and General Counsel Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Bruce Nudell - SunTrust Robin… read more...

ABIOMED's (ABMD) CEO Mike Minogue on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-10-28 10:25:09:000

ABIOMED, Inc. (ABMD) Q2 2018 Earnings Conference Call October 26, 2017 08:00 AM ET Executives Steve McEvoy - Vice President and General Counsel Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Bruce Nudell - SunTrust Robin… read more...

ABIOMED's (ABMD) CEO Mike Minogue on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-10-28 10:25:09:000

ABIOMED, Inc. (ABMD) Q2 2018 Earnings Conference Call October 26, 2017 08:00 AM ET Executives Steve McEvoy - Vice President and General Counsel Michael Minogue - Chairman, President and Chief Executive Officer Robert Bowen - Consultant Analysts Bruce Nudell - SunTrust Robin… read more...

Stocks to watch next week

via: SeekingAlpha at 2017-10-28 09:03:44:000

Key events are scheduled for the companies listed below next week. More news on: Dominion Energy, Inc., Diamond Offshore Drilling Inc., Pfizer Inc., Tech stocks news, Energy stocks news, Consumer stocks news, Healthcare stocks news, Financial stocks news, Read more … read more...

Stocks to watch next week

via: SeekingAlpha at 2017-10-28 09:03:44:000

Key events are scheduled for the companies listed below next week. More news on: Dominion Energy, Inc., Diamond Offshore Drilling Inc., Pfizer Inc., Tech stocks news, Energy stocks news, Consumer stocks news, Healthcare stocks news, Financial stocks news, Read more … read more...

Stocks to watch next week

via: SeekingAlpha at 2017-10-28 09:03:44:000

Key events are scheduled for the companies listed below next week. More news on: Dominion Energy, Inc., Diamond Offshore Drilling Inc., Pfizer Inc., Tech stocks news, Energy stocks news, Consumer stocks news, Healthcare stocks news, Financial stocks news, Read more … read more...

Stocks to watch next week

via: SeekingAlpha at 2017-10-28 09:03:44:000

Key events are scheduled for the companies listed below next week. More news on: Dominion Energy, Inc., Diamond Offshore Drilling Inc., Pfizer Inc., Tech stocks news, Energy stocks news, Consumer stocks news, Healthcare stocks news, Financial stocks news, Read more … read more...

Stocks to watch next week

via: SeekingAlpha at 2017-10-28 09:03:44:000

Key events are scheduled for the companies listed below next week. More news on: Dominion Energy, Inc., Diamond Offshore Drilling Inc., Pfizer Inc., Tech stocks news, Energy stocks news, Consumer stocks news, Healthcare stocks news, Financial stocks news, Read more … read more...

Abiomed beats by $0.16, beats on revenue

via: SeekingAlpha at 2017-10-26 07:08:28:000

Abiomed (NASDAQ: ABMD ): Q2 EPS of $0.54 beats by $0.16 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Abiomed beats by $0.16, beats on revenue

via: SeekingAlpha at 2017-10-26 07:08:28:000

Abiomed (NASDAQ: ABMD ): Q2 EPS of $0.54 beats by $0.16 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Abiomed beats by $0.16, beats on revenue

via: SeekingAlpha at 2017-10-26 07:08:28:000

Abiomed (NASDAQ: ABMD ): Q2 EPS of $0.54 beats by $0.16 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Abiomed beats by $0.16, beats on revenue

via: SeekingAlpha at 2017-10-26 07:08:28:000

Abiomed (NASDAQ: ABMD ): Q2 EPS of $0.54 beats by $0.16 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Abiomed beats by $0.16, beats on revenue

via: SeekingAlpha at 2017-10-26 07:08:28:000

Abiomed (NASDAQ: ABMD ): Q2 EPS of $0.54 beats by $0.16 . More news on: ABIOMED, Inc., Earnings news and commentary, Healthcare stocks news, Read more … read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2017-10-25 17:30:11:000

AAL , ABB , ABMD , AEP , ALKS , ALLE , ALV , ALXN , APD , ARD , ASPS , AUO , AVT , AXTA , BANC , BBW , BC , BCOR , BEN , BGCP , BMS , BMY , BSAC , BSX , BUD , BWA , CCMP , CELG , CFR , CHTR , CMC , CMCSA , CME , CMS , COLB , COP , COR , CPG , CRI , CR… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2017-10-25 17:30:11:000

AAL , ABB , ABMD , AEP , ALKS , ALLE , ALV , ALXN , APD , ARD , ASPS , AUO , AVT , AXTA , BANC , BBW , BC , BCOR , BEN , BGCP , BMS , BMY , BSAC , BSX , BUD , BWA , CCMP , CELG , CFR , CHTR , CMC , CMCSA , CME , CMS , COLB , COP , COR , CPG , CRI , CR… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2017-10-25 17:30:11:000

AAL , ABB , ABMD , AEP , ALKS , ALLE , ALV , ALXN , APD , ARD , ASPS , AUO , AVT , AXTA , BANC , BBW , BC , BCOR , BEN , BGCP , BMS , BMY , BSAC , BSX , BUD , BWA , CCMP , CELG , CFR , CHTR , CMC , CMCSA , CME , CMS , COLB , COP , COR , CPG , CRI , CR… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2017-10-25 17:30:11:000

AAL , ABB , ABMD , AEP , ALKS , ALLE , ALV , ALXN , APD , ARD , ASPS , AUO , AVT , AXTA , BANC , BBW , BC , BCOR , BEN , BGCP , BMS , BMY , BSAC , BSX , BUD , BWA , CCMP , CELG , CFR , CHTR , CMC , CMCSA , CME , CMS , COLB , COP , COR , CPG , CRI , CR… read more...

Notable earnings before Thursday's open

via: SeekingAlpha at 2017-10-25 17:30:11:000

AAL , ABB , ABMD , AEP , ALKS , ALLE , ALV , ALXN , APD , ARD , ASPS , AUO , AVT , AXTA , BANC , BBW , BC , BCOR , BEN , BGCP , BMS , BMY , BSAC , BSX , BUD , BWA , CCMP , CELG , CFR , CHTR , CMC , CMCSA , CME , CMS , COLB , COP , COR , CPG , CRI , CR… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX